Anest. intenziv. Med. 2005;16(2):112-118

The Influence of Sodium Nitroprusside Administration on the Occurence and Abolishion of Vasospasms in Subarachnoid Haemorrhage: a Prospective Interventional StudyIntensive Care Medicine - Original Paper

J. Pachl1, P. Haninec2, T. Tencer1, P. Mizner1, L. Houšťava2, R. Tomáš2, J. Pažout1, M. Fric1, B. Bakalář1, P. Waldauf1
1 Klinika anesteziologie a resuscitace 3. LF UK a Fakultní nemocnice Královské Vinohrady, Praha
2 Neurochirurgická klinika 3. LF UK a Fakultní nemocnice Královské Vinohrady, Praha

Objective:
The aim of the study was to evaluate the effect of preventive and therapeutic use of subarachnoid sodium nitroprusside (SNP) administration in patients with non-traumatic subarachnoid haemorrhage (SAH) in the condition of a multimodal brain tissue monitoring.

Design:
Prospective interventional study.


Setting:
Depts. of Anaesthesiology/CCM and Neurosurgery, Charles University, the 3rd Faculty of Medicine, Prague.

Material and Methods:
All consecutive adult patients admitted in the period 2000-2003 with non-traumatic SAH, Hunt-Hess grade I-IV indicated for neurosurgical intervention were enrolled to the study. In the post -operative period they were treated by controlled mechanical ventilation and a triple-H protocol with a calcium channel blocker. The subarachnoid preventive dose of SNP was administered as a standard medication (initial dose of 1mg) by a catheter inserted to the basal cistern during the neurosurgical procedure. The timing of following doses was directed by dynamic changes of respiratory parameters of the brain tissue in the region of interest assessed by the NeurotrendTM Multiparameter Sensor and changes of a blood flow velocity on the level of the Willisi circuit measured by the transcranial doppler ultrasonography.

Results:
17 patients were enrolled to the study (M/F 11/6, age 27-77 yrs, x = 52.94, SD = 11.34), all survived. No brain infarction developed in studied groups. The increase blood flow velocity was found in three pa tients.

Conclusion:
The preventive subarachnoidal use of the SNP in the bolus dose of 1 mg into the basal cisterns is a perspective preventive strategy. Its efficacy has to be proved on a greater number of patients in the future. The multimodal brain tissue monitoring enables the low-dose titration of the SNP therapy. The therapeutical use of the SNP requires the increase of the application rate.

Keywords: nitric oxide; sodium nitroprusside; subarachnoid administration; cerebral vasospasm; subarachnoid haemorrhage; preventive treatment

Published: April 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pachl J, Haninec P, Tencer T, Mizner P, Houšťava L, Tomáš R, et al.. The Influence of Sodium Nitroprusside Administration on the Occurence and Abolishion of Vasospasms in Subarachnoid Haemorrhage: a Prospective Interventional Study. Anest. intenziv. Med. 2005;16(2):112-118.
Download citation

References

  1. Graves, E. J. Detailed diagnoses and procedures: National Hospital Discharge Survey. Vital Health Stat., 1992, 13, p. 113-225.
  2. Dorsch, N. Therapeutic approaches to vasospasm in subarachnoid hemorrhage Current Opinion in Critical Care, 2002, 8, p. 128-133. Go to original source... Go to PubMed...
  3. Mac Don ald, R. L., Zh an g, Z. D., Cu rry, D. et al. Intracisternal sodium nitroprusside fails to prevent vasospasm in non-human primates. Neurosurgery, 2002 51, 3, 761-768; discussion p. 768-770. Go to original source... Go to PubMed...
  4. Thomas, J. E., Nemirovsky, A., Zelman, V., Giannotta, S. L. Rapid reversal of endothelin-1 induced cerebral vasoconstriction by intrathecal administration of nitric oxid donors. Neurosurgery, 1997, 40, p. 1245-1249. Go to original source... Go to PubMed...
  5. Thomas, J. E., Rosenwasser, R. H. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery, 1999, 44, p. 48-57. Go to original source... Go to PubMed...
  6. Thomas, J. E., Rosenwasser, R. H., Armonda, R. A. et al. Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke, 1999, 30, p. 1409-1416. Go to original source... Go to PubMed...
  7. Raabe, A., Zimmermann, N. et al. Effect of intraventricular SodiumNitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysma patients with severe, medically refractory vasospasm. Neurosurgery, 2002, 50, 5, p. 1006-1013. Go to original source... Go to PubMed...
  8. Thomas, J. E., McGinnis, G. Safety of Intraventricular Sodium Nitroprusside and Thiosulfate for the treatment of Cerebral Vasospasm in the Intensive Care Unite. Stroke, 2002, 33, p. 486-492. Go to original source... Go to PubMed...
  9. Charbel, F. T., Du, X., Hoffman, W. E., Ausman, J. I. Brain tissue PO(2), PCO(2), and pH during cerebral vasospasm. J. Neurosurg., 2002, 97, 6, p. 1302-1305. Go to PubMed...
  10. Gabikian, P., Clatterbuck, R. E., Eberhart, C. G., Tyler, B. M., Tierney, T. S., Tamargo, R. J. Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats. Stroke, 2002, 33, 11, p. 2681-2686. Go to original source... Go to PubMed...
  11. Pathak, A., Mathuriya, S. N., Khandelwal, N., Verma, K. Intermittent low dose sodium nitroprusside therapy for treatment of symptomatic aneurysmal SAH-induced vasospasm. Br. J. Neurosurg., 2003, 17, 4, p. 306-310. Go to original source... Go to PubMed...
  12. Aasled, R., Hubert, P., Nornes, H. A transcranial Doppler method for the evaluation of cerebrovascular spasm. Neuroradiology, 1986, 28, p. 11-16. Go to original source... Go to PubMed...
  13. Fitch, W., Pickard, J. D., Tamura, A., Graham, D. Effects of hypotension induced with sodium nitroprusside on the cerebral circulation before, and one week after, the subarachnoid injection of blood. J. Neurol. Neurosurg. Psychiatry, 1988, 51, 1, p. 88-93. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.